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Impedance cardiography (IC) measures cardiovascular hemodynamics non-
invasively during exercise. However, IC measurements assessing physiological differences 
across treadmill (TM) and cycle (CYC) exercise has not been investigated.  The purpose 
of this study is to investigate whether hemodynamic measurements assessed via IC are 
consistent between TM and CYC exercise at two absolute exercise intensities. Twenty-one 
men (age = 21.4  0.5 y; BMI = 24.4  0.5) completed four exercise tests, two TM and two 
CYC. Within each test, two, five-minute, steady-state stages were completed with targeted 
intensities of 5 (MODex) and 7 (VIGex) metabolic equivalents (METs). Oxygen 
consumption (VO2) was measured by indirect calorimetry. Hemodynamic measures were 
obtained via IC (PhysioFlow, PF07 Enduro) and included cardiac output (CO), heart rate 
(HR), stroke volume (SV), end diastolic volume (EDV), ejection fraction (EF), systemic 
vascular resistance (SVR), contractility index (CTi), and left cardiac work index (LCWi). 
Within treadmill exercise, there were no main effects for trial, except for HR. There were 
no main effects for trial within CYC exercise. Across exercise modes, there were no 
significant differences between TM and CYC exercise for all variables, with the exception 
of higher HR in CYC, and higher SV and EDV in TM. ICCs were strong for all variables 
except VIGex SVR and VIGex LCWi. IC hemodynamic measurements showed strong 
repeatability across modes for all hemodynamic variables during MODex. For VIGex, all 
variables showed strong correlations, except for SVR and LCWi. Lack of agreement may 
be associated with daily variation in hemodynamics or physiological differences across 







Hemodynamics during Exercise 
In cardiovascular physiology, hemodynamics relates to blood circulation. The heart 
ejects blood each beat in order to deliver oxygen throughout the body. The amount of blood 
pumped into the aorta per beat is known as stroke volume (SV), which when multiplied by 
heart rate (HR) determines cardiac output (CO) (American College of Sports Medicine and 
Ehrman, 2014). CO is the central limiting factor in an individual’s VO2 max, which 
represents the greatest amount of oxygen that can be consumed and utilized in the muscle 
tissues. Average resting SV values range from 60-100mL/beat. This discrepancy can be 
attributed to body size and training status (American College of Sports Medicine and 
Ehrman, 2014).  Larger individuals will have a greater SV compared to smaller individuals. 
Furthermore, trained athletes will have a greater SV, compared to untrained individuals, 
due to increased blood volume allowing for a greater venous return and end diastolic 
volume (EDV), which stretches the myocardium causing a more efficient contraction 
compared to untrained individuals (Ekblom et al., 1968; American College of Sports 
Medicine and Ehrman, 2014). Likewise, endurance training increases left ventricular mass 
and compliance that leads to decreases in afterload and end systolic volume (ESV) 
producing a larger SV (Howden et al., 2015). Up to 40% VO2 max, SV increases to 100-
120mL/beat in the average person. Beyond that point, increases in HR have a greater 
influence on the increases in CO (Ekblom et al., 1968; American College of Sports 
Medicine and Ehrman, 2014). In endurance trained athletes, SV may reach 200mL/beat 




individuals (Gledhill, Cox and Jamnik, 1994). There are several methods that can be used 
to measure CO.  
 
Measuring Cardiac Output 
The direct Fick method and dye dilution are considered the “gold standards” for 
measuring CO (Warburton et al., 1999). Both methods use catheters in or near the heart. 
The direct Fick method allows for the simultaneous collections of arterial and venous 
blood, so the atrial-venous oxygen difference (a-vO2) can be calculated. SV can then be 
calculated using the Fick Equation since HR is known (Cournand et al., 1945). In the dye 
dilution technique, a known amount of dye is injected into the vena cava or pulmonary 
artery. A densitometer measures the downstream blood flow calculating SV from the 
change in fluid density (Ekblom et al., 1968). Thermodilution is a similar technique to dye 
dilution, but a cold solution of a given temperature is injected instead of dye. The change 
in temperature of the infused solution is used to calculate SV (Scherhag, Kaden and 
Kentschke, 2005). Although these methods are considered valid (Cournand et al., 1945; 
Ekblom et al., 1968; Warburton et al., 1999), their invasive nature can make them difficult 
to utilize during exercise. These issues led to the development several of non-invasive CO 
measuring techniques.  
Non-invasive methods used to calculate CO include CO2 rebreathing (Faulkner et 
al., 1971), acetylene rebreathing (Bell et al., 2003), inert gas rebreathing (Siebenmann et 
al., 2015), doppler echocardiography (Bogui et al., 2013), pulse contour analysis 
(Siebenmann et al., 2015), and impedance cardiography (Kubicek et al., 1966; Sramek, 




CO2 rebreathing requires the subject to inhale a known concentration of CO2 to 
create equilibrium with the lungs. At which point, a pulse oximeter or arterial blood sample 
can be used to determine the concentration of arterial O2. By using the Fick Equation, CO 
can be estimated (Faulkner et al., 1971).  
Acetylene rebreathing requires a known mixture of gas to be inhaled by the 
subjects. Three breaths are required to achieve equilibrium between the gas supply and the 
lungs. Inert gas rebreathing follows a similar concept where the inert gas diffused into the 
blood, but does not bind with hemoglobin. The rate at which the concentrations of gas 
decreases from the source is proportional to CO (Bell et al., 2003; Siebenmann et al., 2015).  
Doppler echocardiography uses sound waves and ultrasound imaging to measure 
left ventricle cross-sectional area. SV per cardiac cycle is estimated to be the difference in 
cross-sectional measurements between EDV and ESV (Bogui et al., 2013).  
Pulse contour analysis measures SV using a fingertip clamp to analyze the arterial 
impedance per pulse beat. The changes in pulse systolic area is used to estimate CO. 
Although this method is considered non-invasive, thermodilution is used to calibrate the 
device  (Siebenmann et al., 2015).  
Impedance cardiography (ICG) is a similar concept to pulse contour analysis. 
However, the impedance is measured in the thoracic region, and the calibration process 
does not entail an invasive component. ICG attempts to continually measure CO through a 
noninvasive technique based off Ohm’s Law, which states that Resistance = Voltage / 
ampere. Electrical current will travel the path of least resistance, so as the heart ejects blood 
from the left ventricle, the current is “absorbed” by the ejected blood. The degree of 




Hemodynamics across Treadmill and Cycle Exercise 
When comparing treadmill and cycle exercise at a given HR, percent VO2 max of 
the given mode is statistically higher in cycling compared to treadmill exercise (McArdle 
and Magel, 1970). When comparing treadmill and cycle exercise at a given VO2, CO is 
equal across modes; however, this is a result of greater SV in running compared to a higher 
HR in cycling at the given intensity (Hermansen, Ekblom and Saltin, 1970). Furthermore, 
at a given percent of VO2 max, mean arterial pressure (MAP) was no difference across 
exercise modes (Hermansen, Ekblom and Saltin, 1970).  
At maximal exercise, CO is greater in running due to a greater SV with equivalent 
maximal heart rates across modes, which allows for 6-11% more oxygen uptake in 
treadmill exercise  (Hermansen, Ekblom and Saltin, 1970; Faulkner et al., 1971). 
Furthermore, MAP can be 10% greater in maximal cycling compared to maximal treadmill 
exercise (Hermansen, Ekblom and Saltin, 1970). To compare hemodynamic measures 
across exercise modes at submaximal and maximal intensities, Hermansen and Faulker 
used dye dilution and CO2 rebreathing techniques, respectively. 
 
ICG History 
Nyboer (Nyboer, Kreider and Hannapel, 1950) first implemented this practice by 
placing two metal strips proximally and two strips distally on the subjects’ extremities to 
measure the change in blood volume. This concept was later adopted by Kubicek in the 
1960s to measure stroke volume by repositioning the metal strips to the neck and around 
the xiphoid region (Kubicek et al., 1966). These metal strips act as conducting and sensing 




a low amplitude, high frequency current while the bottom strip on the neck and top strip 
on the thorax read the changes in volume by this equation: 







Where  = the electrical resistivity of blood at 100kHz (which has an average value of 150 
ohm-cm); L = the mean distance between the two inner electrodes in cm; Zi = the 
impedance between the two inner electrodes in ohms; and dZ = the extrapolated maximum 
impedance change during systole (Kubicek et al., 1966). When using Kubicek’s equation 
for ICG, it must be assumed that the thorax is cyndrical in shape. In the 1980s, Sramek 
critiqued Kubicek’s equation by creating a constant for blood resistivity and altering the 






Where C = the average thoracic circumference at the xiphoid processes in cm; L = the 
average distance between the sensing electrodes in cm; Zi = thoracic impedance in ohms; 
T = ventricular ejecting time in seconds, and dZ/sec is the maximum rate of impedance 
change in ohms/sec. When impedance cardiographs are designed to use the Sramek 
equation, SV values were underestimated when the individual was 15-20% overweight; as 
a result, Berstein altered the equation further to enhance ICG accuracy by accounting for 
the individual’s body size (Bernstein, 1986): 
𝑆𝑉 =  𝛿 ∗  
(0.17𝐻)3
4.2







Where  is the weight correction factor for the individual and H is height in cm. Though 
different non-invasive methods, including ICG, are available to measure stroke volume, 
use of these methods compromises validity.  
In recent years, a new ICG device, known as the PhysioFlow, has been developed 
to continually measure hemodynamics at rest and during exercise. These hemodynamic 
measures include CO, cardiac index (CI), SV, stroke volume index (SVi), ventricular 
ejection time (VET), estimated ejection fraction (EF), estimated end diastolic volume 
(EDV), and systemic vascular resistance (SVR) (Charloux et al., 2000). CI and SVi are 
measures of CO and SV, respectively, that are normalized to the body surface area (BSA) 
of an individual.  
 The PhysioFlow uses six electrodes: two above the supraclavicular fossa, two level 
with the xiphoid processes left of the spine, and two ECG electrodes located at V1 and V6 
(Charloux et al., 2000).  Unlike previous ICG devices, the electrodes placed on xiphoid 
processes can vary, and the recorded values will retain similar values (r=0.995)  (Tan, Lai 
and Hwang, 2006).  
The formula that calculates the hemodynamics slightly differs from previous ICG 
devices (Charloux et al., 2000):  
𝐶𝑂 = 𝑓𝑐 ∗ 𝑆𝑉𝑖 ∗ 𝐵𝑆𝐴 
Where fc is the heart rate of the subject in beats per minute calculated off the R-R interval 
of the ECG leads. Body mass and height are entered into the device, allowing the 
PhysioFlow to calculate BSA. The high frequency of 75kHz and low amplitude of 1.8mA 
is able to calculate the amount of blood ejected per cardiac cycle. Knowing the volume of 




PhysioFlow to calculate CO and SV. Greater details describing the algorithms used by the 
PhysioFlow have been described previously (Charloux et al., 2000).  
 
ICG Validity  
 Several studies have validated the PhysioFlow’s measurements against the direct 
Fick Method (Richard et al., 2001; Tordi et al., 2004) and CO2 rebreathing (Tordi et al., 
2004), and dye-dilution (Robach et al., 2008) in healthy (Richard et al., 2001; Tordi et al., 
2004; Robach et al., 2008) as well as clinical populations (Charloux et al., 2000; Ferreira 
et al., 2012). In some cases, the PhysioFlow’s measurements can over-estimate when 
compared to the direct Fick Method (Bougault, 2005; Siebenmann et al., 2015), inert gas 
rebreathing (Siebenmann et al., 2015), and pulse contour analysis (Siebenmann et al., 
2015).  On the other hand, the PhysioFlow’s measurements have been underestimated 
when compared to single breath acetylene uptake method (Wang et al., 2014).  
Researchers may opt to use the PhysioFlow due to the additional variables, other 
than CO, that can be recorded. The algorithm that the PhysioFlow uses calculates additional 
variables, such as left cardiac work index (LCWi), early diastolic filling ratio (EDFR), 
contractility index (CTi), and systemic vascular resistance index (SVRi). LCWi is the 
amount of work the left ventricle must produce to eject blood in relation to the individual’s 
BSA. EDFR is the ratio of peak left ventricle filling between early and late diastole. CTi is 
the heart’s force production, independent of preload and afterload. SVRi is the afterload of 
a cardiac cycle in relation to BSA. These variables are continuously recorded through the 
duration of exercise. Having the capability to analyze multiple variables with a single 






 To date, no study has assessed the physiological differences across treadmill and 
cycle exercise using PhysioFlow ICG.  Therefore, the purpose of the present study is to 
investigate whether hemodynamic measures assessed via PhysioFlow impedance 
cardiography are consistent within and across running and cycling exercise tests at two 
absolute submaximal intensities. It is hypothesized that the PhysioFlow impedance 
cardiography measures within an exercise mode will be high (ICC 0.7). However, it is 
hypothesized that SV during running will be higher compared to cycling.  
Assumptions 
 It is assumed that all subjects followed pre-test instructions of fasting and 
abstaining from caffeine and alcohol four hours prior to testing as well as refrained from 
strenuous exercise 24 hours prior to testing. It must be assumed that the ACSM metabolic 
equations are accurate as the cycling protocol will be tailored to each subject due to 
differences in body weight from subject to subject.  
Limitations 
 The sample of subjects in this study was not completely random as subjects were 
recruited through word-of-mouth recruiting and bulk-email requests advertising the need 
for subjects. The present study cannot validate the PhysioFlow due to lack of access to 






Delimitations of this study include the use of healthy male subjects, 18 years and 
older. Female hemodynamics vary throughout the different stages of the menstrual cycle 
causing variation that is difficult to control. Studies were performed at the same time of 









 Twenty-one (n=21) male subjects, who were all apparently healthy with no 
previous diagnosis of cardiovascular, pulmonary, or metabolic disease were recruited from 
the James Madison University campus.  Females were not recruited due to hormonal 
changes in the menstrual cycle that could lead to decreased systemic vascular resistance 
altering hemodynamics (Chapman et al., 1997). Individuals who could not participate in 
vigorous exercise due to orthopedic limitations were also excluded from the study. All 
experimental protocols were approved by the Institutional Review Board for Human 
Subject Research at James Madison University prior to testing. All subjects completed the 
informed consent prior to participation.  
 
Pre-test 
 Subjects were asked to visit JMU’s Human Performance Lab on four separate 
occasions for approximately 1 hour each visit. Subjects were fasted and abstained from 
caffeine and alcohol for four hours prior to testing. Subjects were given two questionnaires 
to complete: the Physical Activity Readiness Questionnaire (PARQ) and the International 
Physical Activity Questionnaire, Short Form (IPAQ). The PARQ was completed to ensure 
subjects were cleared for exercise. IPAQ was administered to obtain self-reported physical 
activity levels. Subject height and weight were recorded to the nearest 0.5cm and 0.1kg, 






 Hemodynamic variables were measured using the PhysioFlow (PF07 Enduro, 
Manatec Biomedical; Paris, France). Primary hemodynamic variables included CO, HR, 
and SV. Secondary variables consisted of end diastolic volume (EDV), ejection fraction 
(EF), systemic vascular resistance (SVR), contractility index (CTi), and left cardiac work 
index (LCWi). Six electrodes were used for this device: two electrodes placed above the 
supraclavicular fossa, two placed just left of the spine dorsally in line with the xiphoid 
processes, and two ECG electrodes (V1 and V6). Prior to electrode placement, each site 
was shaved to remove body hair, alcohol pads then cleaned the site, and lastly skin prep 
gel was applied in the specific area to lower impedance and improve signal quality. After 
electrodes were placed in the proper sites, subjects laid in the supine position for resting 
blood pressure measurements in accordance with the ACSM guidelines (American College 
of Sports Medicine, 2013). Thereafter, the PhysioFlow was auto-calibrated after 30 heart 
cycles. Blood pressure was measured a second time in the position of exercise (i.e. standing 
or sitting on cycle ergometer) prior to testing. The PhysioFlow recorded hemodynamic 
measures in 10 second averages at rest and throughout the exercise test in addition to a 3-
minute recovery period.  
 
Exercise Tests  
 Subjects performed a total of four graded exercise tests, two on a treadmill (TM1 
and TM2) and two on an electronically braked cycle ergometer (CYC1 and CYC2). 
Oxygen consumption was measured through indirect calorimetry via a metabolic cart 




final three tests were conducted in a randomized order. All four tests were completed with 
a minimum of 48 hours between tests and occurred at the same time of day for each subject. 
The custom treadmill protocol was established as follows: 2.6mph @ 0% (1min), 3.1mph 
@ 1.5% (1min), 3.6mph @ 2.5% (5 min), 4mph @ 3.5% (1 min), 4mph @ 5.5% (5min), 
5mph @ 1% (1min), 5.3mph @ 2.5% (1min), 5.6mph @ 5% (1min), 6.1mph @ 6.5% 
(1min), 6mph @ 10.5% (1min), 6mph @ 14% (1min), 6mph @ 16.5%, 6.2mph @ 17.5%, 
and 6.4mph @ 18.5% (if reached, until exhaustion).  
The cycling test protocol will be as follows: 2 METs (1 min), 3.4 METs (1 min), 5 
METs (5 min), 6.4 METs (1 min), 7 METs (5 min), 8.4 METs (1 min), 9.8 METs (1 min), 
11.2 METs (1 min), 12.6 METs (1 min), 14 METs (1 min), 15.4 METs (1 min), and 16.8 
METs (if reached, until fatigue). Watts for the given METs will be estimated using the 
metabolic equations (American College of Sports Medicine, 2013).      
Subjects exercised to volitional exhaustion, an inability to maintain 60 revolutions 
per minute on the cycle ergometer, or if the subject reported any adverse effects as outlined 
in the ACSM Guidelines (American College of Sports Medicine, 2013). The two 5-minute 
stages corresponded to moderate and vigorous exercise (MODex and VIGex) with targeted 
intensities of 5 and 7 METs, respectively (American College of Sports Medicine, 2013). 
CYC1 and CYC2 MET levels for a give stage were estimated using the metabolic equations 
(American College of Sports Medicine, 2013). Blood pressure was measured 3 minutes 
into the steady-state stages. PhysioFlow data during the final 2 minutes of MODex and 
VIGex stages were averaged together to examine the PhysioFlow’s test re-test reliability.  
Cycling watt intensity for MODex and VIGex were estimated from TM1’s 




measurements during the cycling tests. If the subject did not achieve the desired VO2 value 
within 2 minutes of the MODex and VIGex stages, watts were adjusted accordingly to 
mimic TM1 VO2 values at the respective stages. This was done to ensure VO2 was equal 
across treadmill and cycle exercise for the respective stages.    
 
Statistical Analyses   
 Two-way ANOVAs with a Bonferroni correction were used to determine main 
effects for trial and intensity within an exercise mode. For across mode analysis, a two-
way ANOVA with Bonferroni correction was used to determine main effects for mode and 
intensity for the averages of the TM trials and the averages of the CYC trials. Intraclass 
correlation coefficients (ICC) determined the agreement within and across exercise modes 
at the absolute submaximal intensities. Coefficients of variation (CV) were used to 
determine the variability within and across exercise trials. Statistical significance was set 
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Impedance cardiography (IC) measures cardiovascular hemodynamics non-
invasively during exercise. However, IC measurements assessing physiological differences 
across treadmill (TM) and cycle (CYC) exercise has not been investigated.  The purpose 
of this study is to investigate whether hemodynamic measurements assessed via IC are 
consistent between TM and CYC exercise at two absolute exercise intensities. Twenty-one 
men (age = 21.4  0.5 y; BMI = 24.4  0.5) completed four exercise tests, two TM and two 
CYC. Within each test, two, five-minute, steady-state stages were completed with targeted 
intensities of 5 (MODex) and 7 (VIGex) metabolic equivalents (METs). Oxygen 
consumption (VO2) was measured by indirect calorimetry. Hemodynamic measures were 
obtained via IC (PhysioFlow, PF07 Enduro) and included cardiac output (CO), heart rate 
(HR), stroke volume (SV), end diastolic volume (EDV), ejection fraction (EF), systemic 
vascular resistance (SVR), contractility index (CTi), and left cardiac work index (LCWi). 
Within treadmill exercise, there were no main effects for trial, except for HR. There were 
no main effects for trial within CYC exercise. Across exercise modes, there were no 
significant differences between TM and CYC exercise for all variables, with the exception 
of higher HR in CYC, and higher SV and EDV in TM. ICCs were strong for all variables 
except VIGex SVR and VIGex LCWi. IC hemodynamic measurements showed strong 
repeatability across modes for all hemodynamic variables during MODex. For VIGex, all 
variables showed strong correlations, except for SVR and LCWi. Lack of agreement may 
be associated with daily variation in hemodynamics or physiological differences across 






In cardiovascular physiology, cardiac output (CO) is the product of stroke volume 
(SV) and heart rate (HR) and is a central limiting factor in an individual’s maximal oxygen 
consumption (VO2 max) (American College of Sports Medicine and Ehrman, 2014). 
Resting SV ranges from 60-100mL/beat, with body size and training status being the most 
influential factors (American College of Sports Medicine and Ehrman, 2014). While 
exercising, a HR of 120 beats per minute (bpm) is typically the threshold of SV plateau at 
120mL/beat; however, endurance trained athletes may achieve values as high as 
200mL/beat with no plateau through maximal exercise (Gledhill, Cox and Jamnik, 1994). 
Additionally, exercise mode can influence CO dynamics. At a given VO2, CO is equal 
between treadmill and cycling; however, this is a result of higher SV in running compared 
to a higher HR in cycling at the given intensity (Hermansen, Ekblom and Saltin, 1970). At 
maximal exercise, CO is greater in running due to a greater SV with equivalent maximal 
heart rates across modes (Hermansen, Ekblom and Saltin, 1970; Faulkner et al., 1971).  
There are several methods used to determine CO. The direct Fick method and dye 
dilution have been considered the “gold standard” methods (Warburton et al., 1999). 
Though these techniques are considered the most valid, their invasive nature can become 
difficult and risky during exercise due to catheters inserted in or near the heart (Warburton 
et al., 1999). This issue led to the development of several non-invasive methods, including 
carbon dioxide (CO2) rebreathing, acetylene rebreathing, inert gas rebreathing, Doppler 
echocardiography, pulse contour analysis, and impedance cardiography (ICG). Of these, 




ICG is based off Ohm’s Law with the concept first introduced by Nyboer (Nyboer, 
Kreider and Hannapel, 1950) and later developed by Kubicek (Kubicek et al., 1966) to 
measure thoracic impedance. Sramek (Sramek, 1982) and Bernstein (Bernstein, 1986) 
refined the technique further, accounting for thoracic volume and body size, respectively.   
Most recently, an ICG device, known as the PhysioFlow, has been developed to 
continually measure hemodynamics at rest and during exercise and has been validated 
against the direct Fick method (Charloux et al., 2000; Richard et al., 2001) and dye dilution 
(Robach et al., 2008). To date, no study has tested the physiological differences across 
exercise modes at absolute submaximal intensities using PhysioFlow ICG.  Therefore, the 
purpose of the present study was to investigate whether hemodynamic measures assessed 
via PhysioFlow impedance cardiography were consistent across running and cycling 
exercise tests at two absolute submaximal intensities. It was hypothesized that the 
PhysioFlow impedance cardiography measures within an exercise mode will be 
reproducible (ICC 0.7). However, it was hypothesized that stroke volume during running 




 Twenty-one (n=21) male subjects, who were all apparently healthy with no 
previous diagnosis of cardiovascular, pulmonary, or metabolic disease were recruited from 
the James Madison University campus.  Females were not recruited due to hormonal 
changes in the menstrual cycle that could lead to decreased systemic vascular resistance 
altering hemodynamics (Chapman et al., 1997). Individuals who could not participate in 




experimental protocols were approved by the Institutional Review Board for Human 
Subject Research at James Madison University prior to testing. All subjects completed the 
informed consent prior to participation.  
 
Pre-test 
 Subjects were asked to visit JMU’s Human Performance Lab on four separate 
occasions for approximately 1 hour each visit. Subjects were fasted and abstained from 
caffeine and alcohol for four hours prior to testing. Subjects were given two questionnaires 
to complete: the Physical Activity Readiness Questionnaire (PARQ) and the International 
Physical Activity Questionnaire, Short Form (IPAQ). The PARQ was completed to ensure 
subjects were cleared for exercise. IPAQ was administered to obtain self-reported physical 
activity levels. Subject height and weight were recorded to the nearest 0.5cm and 0.1kg, 
respectively.    
 
Hemodynamic Measures 
 Hemodynamic variables were measured using the PhysioFlow (PF07 Enduro, 
Manatec Biomedical; Paris, France). Primary hemodynamic variables included CO, HR, 
and SV. Secondary variables consisted of end diastolic volume (EDV), ejection fraction 
(EF), systemic vascular resistance (SVR), contractility index (CTi), and left cardiac work 
index (LCWi). The six electrodes were used for the device and placed in identical fashion 
to previous literature (Charloux et al., 2000). Then subjects laid in the supine position for 
resting blood pressure measurements in accordance with the ACSM guidelines (American 




30 heart cycles. Blood pressure was measured a second time in the position of exercise (i.e. 
standing or sitting on cycle ergometer) prior to testing. The PhysioFlow recorded 
hemodynamic measures in 10 second averages at rest and throughout the exercise test in 
addition to a 3-minute recovery period.  
 
Exercise Tests  
 Subjects performed a total of four graded exercise tests, two on a treadmill (TM1 
and TM2) and two on an electronically braked cycle ergometer (CYC1 and CYC2). 
Oxygen consumption was measured through indirect calorimetry via a metabolic cart 
(Parvo Medics TrueOne 2400; Sandy, UT). TM1 was designated as the first visit while the 
final three tests were conducted in a randomized order. All four tests were completed with 
a minimum of 48 hours between tests and occurred at the same time of day for each subject. 
The custom treadmill and cycle protocols can be seen in Table 1.  
Subjects exercised to volitional exhaustion, an inability to maintain 60 revolutions 
per minute on the cycle ergometer, or if the subject reported any adverse effects as outlined 
in the ACSM Guidelines (American College of Sports Medicine, 2013). The two 5-minute 
stages corresponded to moderate and vigorous exercise (MODex and VIGex) with targeted 
intensities of 5 and 7 METs, respectively (American College of Sports Medicine, 2013). 
CYC1 and CYC2 MET levels for a give stage were estimated using the metabolic equations 
(American College of Sports Medicine, 2013). Blood pressure was measured 3 minutes 
into the steady-state stages. PhysioFlow data during the final 2 minutes of MODex and 




Cycling watt intensity for MODex and VIGex were estimated from TM1’s 
averaged VO2 at the respective stage. These estimations were confirmed with VO2 
measurements during the cycling tests. If the subject did not achieve the desired VO2 value 
within 2 minutes of the MODex and VIGex stages, watts were adjusted accordingly to 
mimic TM1 VO2 values at the respective stages. This was done to ensure VO2 was equal 
across treadmill and cycle exercise for the respective stages.    
 
Statistical Analyses   
 Two-way ANOVAs with a Bonferroni correction were used to determine main 
effects for trial and intensity within an exercise mode. For across mode analysis, a two-
way ANOVA with Bonferroni correction was used to determine main effects for mode and 
intensity for the averages of the TM trials and the averages of the CYC trials. Intraclass 
correlation coefficients (ICC) determined the agreement within and across exercise modes 
at the absolute submaximal intensities. Coefficients of variation (CV) were used to 
determine the variability within and across exercise trials. Statistical significance was set 
a priori at p<0.05.   
 
Results 
Subjects characteristics are listed in Table 2. Hemodynamic averages are displayed 
in Tables 3 and 4 for primary and secondary variables, respectively. For the treadmill, there 
were no main effects for trial for hemodynamic variables, with the exception of HR. For 
cycle exercise, there were no main effects for trial for any hemodynamic variable.  
Within treadmill exercise, ICC for primary and secondary hemodynamic variables 




For MODex and VIGex, CVs ranged from 3.4-8.7% and 3.1-10.5%, respectively. Within 
MODex of cycle, all correlation coefficients achieved r ≥ 0.7, indicating strong agreement, 
with the exception of SVR (r = 0.68) and CTi (r = 0.47) with CVs ranging from 2.3-12.1%. 
For VIGex cycling, all hemodynamic variables had correlation coefficients r <0.7, except 
for VO2 (r = 0.93) and HR (r = 0.85) indicating good agreement for the two primary 
variables. For VIGex cycling, CVs ranged from 3.5-15.1%.  
 For across mode analyses, the average values of TM1 and TM2 were compared to 
the averages of CYC1 and CYC2. Across treadmill and cycle exercise, there was an 
interaction effect for trial by intensity for CTi but not for other variables. There were no 
main effects for trial for any hemodynamic variable, with the exception of greater HR in 
cycling and greater SV and EDV in treadmill exercise.  
Across treadmill and cycle exercise all primary and secondary variables during 
MODex had reliability coefficients r ≥ 0.7. For VIGex, CO, HR, SV, EDV, EF, and CTi 
exhibited reliability coefficients r ≥ 0.7, indicating strong agreement. However, SVR and 
LCWi achieved reliability coefficients of r < 0.7 showing a lack of agreement across 
treadmill and cycle exercise. CVs ranged from 2.7-9.3% and 2.1-10.5% for MODex and 
VIGex, respectively across exercise modes. 
Discussion  
 The purpose of this study was to determine the physiological differences across 
treadmill and cycle exercise utilizing PhysioFlow ICG at moderate and vigorous exercise 
intensities. The present study found strong agreement within treadmill exercise and 




majority of primary and secondary hemodynamic variables for both intensities when 
comparing across treadmill and cycle exercise.   
The current study is the first to examine the reliability of PhysioFlow ICG within 
treadmill exercise. For MODex and VIGex intensities, all primary and secondary 
hemodynamic variables were in strong agreement. There were no main effects for trials 
within treadmill exercise with the exception of HR. For a given stage, HR decreased by 4 
bpm from TM1 to TM2. Sime et. al. discovered that HR statistically decreased in 
subsequent testing in about one-third of subjects with one week of separation between trials 
possibly due to task and setting familiarity (Sime et al., 1972). As there was no 
familiarization trial performed in the current study, this phenomenon could have occurred 
as TM1 was designated as the first visit.   
Previous literature has investigated the PhysioFlow ICG’s reproducibility in cycle 
exercise. Schultz et. al. determined the reliability during submaximal cycle exercise at 70% 
of age predicted max heart rate (APMHR) during a 5-minute steady state bout (Schultz et 
al., 2012). Hemodynamic data was recorded for 5 minutes once steady state was achieved 
at the given workload. Schultz observed all ICC’s for hemodynamic variables achieving r 
≥ 0.7 during all exercise stages. Schultz’s 70% APMHR best corresponds with the current 
study’s MODex as both are considered moderate intensities (American College of Sports 
Medicine, 2013). The present study’s MODex showed similar results to Schultz et. al. 70% 
APMHR with all ICC achieve r ≥ 0.7, with the exception of SVR (r = 0.68) and CTi (0.47). 
The lack of agreement in SVR is uncertain due to no statistical differences in systolic and 
diastolic blood pressure (SBP and DBP). However, the lack of agreement in CTi may be 




two standard deviations in MODex CTi for CYC1, and when omitted from the cycle ICC 
analysis, r = 0.91 (p <0.001).  
VIGex of the current study was designated to be a vigorous submaximal intensity 
at an absolute workload. In contrast to treadmill exercise, cycle exercise correlation 
coefficients in VIGex were r < 0.7 for all variables except for HR. The low correlations 
may be attributed to the vigorous nature of the steady-state stage in an unfamiliar exercise 
mode, as most subjects were not cycle trained. This could have resulted in a different 
physiological response in the higher intensity stage from CYC1 to CYC2. Respiratory 
exchange ratio (RER) was significantly higher in cycle exercise compared to treadmill at 
the vigorous intensity (0.94 ± 0.07 versus 0.87 ± 0.04, p<0.001). The difference in RER 
suggests that VIGex cycling was relatively more difficult compared to treadmill exercise 
at the same VO2. In a previous study where subjects performed maximal treadmill and 
cycling tests, RER was significantly higher in cycling at 150 and 170 bpm (McArdle and 
Magel, 1970). Furthermore, percent VO2 max was significantly higher at 150 and 170 bpm 
in cycling compared to treadmill suggesting cycle exercise was more demanding at a given 
heart rate.   
When comparing across modes, SV significantly increased in treadmill exercise 
possibly due to a greater EDV allowing for a more efficient contraction via the Frank-
Starling mechanism. Contrarily in cycle exercise, there was no change in SV, EDV, EF, 
and CTi with an increase in intensity. SV traditionally plateaus at 40% VO2 max (Vella 
and Robergs, 2005). MODex VO2 was calculated to be 45% of cycling VO2 max for both 
cycle trials suggesting the plateau in SV may result from no change in EDV, CTi, and EF 




measured to be statistically higher (p=0.01) to create an equal CO at the given VO2 across 
exercise modes. Similar results were found previously while using the gold-standard, dye 
dilution (Hermansen, Ekblom and Saltin, 1970). During MODex and VIGex, cycling HR 
averaged to be 4 and 6 bpm higher compared to treadmill for the given stage. These values 
were at the lower end of Hermansen’s 6-10 bpm difference between cycle and treadmill 
exercise. Hermansen attributed the difference in hemodynamics due to increased pressure 
in cycling that may impede blood flow to the muscle.  
In the present study, mean arterial pressure (MAP) was not statistically different 
across exercise modes at a given intensity; however, this is due to statistically higher SBP 
(MODex SBP: 140 ± 11 versus 146 ± 14 mmHg, p=0.001; VIGex SBP: 158 ± 3 versus 169 
± 4mmHg, p=0.002) and statistically lower DBP (MODex DBP: 67 ± 8 versus 60 ± 6 
mmHg, p=0.001; VIGex DBP: 64 ± 1 versus 56 ± 1 mmHg, p = 0.002) in cycling compared 
to treadmill. The higher SBP in cycle exercise can be attributed to prolonged isometric 
contractions and vessel compression as a result of pedaling mechanics versus running 
(Palatini, 1988). The vessel compression during cycling reduces the compliance of the 
arteries causing a greater decrease in DBP (London and Guerin, 1999). As a result, HR 
may be increased at a given VO2 to maintain adequate blood flow with the increased vessel 
compression during cycling.  
There are some physiological mechanisms that may explain the lack of agreement 
across exercise modes. Previous literature has reported SVR as the product of MAP and 
mean right atrial pressure (MRAP) divided by CO (Stamler et al., 1994). There were no 
significant differences in MAP or CO across modes during VIGex. Therefore, the lack of 




not measured in the current study, so this cannot be concluded with certainty. Although 
MAP was not statistically different during VIGex, the lack of agreement may extend from 
the observed differences in SBP and DBP across exercise modes.  
 Similarly, LCWi is calculated as the difference between MAP and left ventricular 
end diastolic pressure (LVEDP) multiplied by cardiac index (CI), which is CO accounted 
for body surface area (Ferguson, Gregg and Shadle, 1954). The lack of agreement across 
exercise modes could also be attributed to the observed differences in SBP and DBP. 
Moreover, with EDV statistically greater in treadmill exercise, the LVEDP would have 
been greater compared to cycling suggesting that the differences in pressure may lead to 
the lack of agreement in VIGex LCWi across modes  (Burkhoff, Mirsky and Suga, 2005).  
 Lastly, there was a significant mode by intensity interaction effect for CTi across 
exercise modes with a trending main effect for intensity (p = 0.07). CTi is known as the 
heart’s inherent ability to produce force in relation to an individual’s body surface area, 
independent of changes in preload and afterload (Bombardini, 2005). However, in a recent 
review by Bombardini discussing myocardial contractility, it is suggested that greater force 
will be produced with an increase in sarcomere length at a given calcium ion concentration 
(Bombardini, 2005). In treadmill exercise, there may be increased sarcomere length due to 
greater EDV as intensity increases. As a result, contractility may be increasing more in 
treadmill exercise compared to cycle as intensity increases.  
Limitations 
 The sample of subjects in this study was not completely random as subjects were 
college-aged males recruited through word-of-mouth recruiting and bulk-email requests 




study as using a homogeneous population would likely reduce the hemodynamic variable 
ICCs.  
The present study cannot validate PhysioFlow ICG due to lack of access to direct 
measurements, so the present study must rely on previous research to validate the device 
(Charloux et al., 2000; Richard et al., 2001; Robach et al., 2008). It is important to note 
that lack of agreement may reflect physiological differences across exercise modes, as well 
as day-to-day variation in hemodynamics with the remainder of variability associated with 
the device.   
Future research may wish to investigate PhysioFlow ICG measures in subjects who 
are trained in running and cycling exercise, such as duathlon participants or triathletes. This 
may establish better agreement across modes or in VIGex of cycling. Experimenting across 
broader range of exercise modes would be beneficial to determine if different postural 
positions effect hemodynamics during exercise. Furthermore, future research may wish to 
utilize invasive methods to validate the hemodynamic differences observed between TM 
and CYC.  
Conclusions  
 Across treadmill and cycle exercise, the PhysioFlow ICG showed higher HR with 
lower SV and EDV in cycling exercise for a given VO2, which is in accordance with 
previous literature using a gold standard technique. Correlation coefficients were strong 
across exercise mode during MODex for all hemodynamic variables. For VIGex, all 
hemodynamic variables were strong with the exception of SVR and LWCi. However, the 
lack of agreement may be explained by the physiological differences observed across 




day-to-day variation in hemodynamics and physiological differences across exercise 
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Table 1  Treadmill and Cycling Protocols   
Time TM Speed (mph) TM Grade (%)  Cycle METs 
     
0:01 - 0:59 2.6 0  2 
1:00 - 1:59 3.1 1.5  3.4 
2:00 - 6:59* 3.6 2.5  5 
7:00 -7:59 4 3.5  6.4 
8:00 - 12:59* 4 5.5  7 
13:00 – 13:59 4.6 0  8.4 
14:00-14:59 5 1  9.8 
15:00 – 15:59 5.3 2.5  11.2 
16:00 – 16:59 5.6 5  12.6 
17:00 – 17:59 6.1 6.5  14 
18:00 – 18:59 6 10.5  15.4 
19:00-19:59 6 14  16.8 
20:00-20:59 6 16.5  18.2 
21:00-21:59 6.2 17.5  19.6 
22:00-22:59 6.4 18.5  21 









21.4  0.5 
IPAQ (METminweek-1) 
 
4825.7  801.1 
Height (cm) 
 
178.9  2.0 
Weight (kg) 
 
73.2  2.7 
BMI (kg/m2) 
 




51.5  1.5 
Mean (SD) cm: IPAQ: International Physical Activity Questionnaire.  MET: 





 Table 3  Mean Values of Primary Hemodynamic Variables for Treadmill and Cycle 
exercise at moderate and vigorous intensity.  
 
 Averaged TM Averaged CYC 
     
MODex VO2  
(mLmin-1) 
1571.5  253.6 1565.0  260.4 
VIGex VO2  
(mLmin-1) 
 
2248.6  391.9† 2326.2  432.8†  
MODex CO 
(Lmin-1) 




19.6  2.9† 18.8  2.6†  
MODex HR 
(beatsmin-1) 




145  14† 151  17† 
MODex SV 
(mLbeat-1) 




134.5  18.0† 124.6  14.3 
Mean (SD). * indicates a significant (p <0.05) main effect for mode of across treadmill (TM) and cycle 
(CYC) exercise. † indicates significant (p <0.05) main effect for intensity within a mode. MODex: 
moderate exercise. VIGex: vigorous exercise. VO2: oxygen consumption. CO: cardiac output. HR: heart 








Table 4  Mean Values of Secondary Hemodynamic Variables for Treadmill and Cycle 
exercise at moderate and vigorous intensity. 
 Averaged TM Averaged CYC 
     
MODex EDV 
(mL) 




161.8  25.2†  150.4  25.4 
MODex EF 
(%) 




83.8  6.8  83.4  7.1 
MODex SVR 
(dynscm-5) 




396.8  66.6†  400.0  53.1† 
MODex CTi 
 
350.7  67.9  369.0  98.3 
VIGex CTi  
 
 
400.4  88.6†  369.2  84.3 
MODex LCWi 
(kgmm2-1) 




12.9  2.0†  12.0  1.8† 
Mean (SD). * indicates a significant (p <0.05) main effect for mode of across treadmill (TM) and cycle 
(CYC) exercise. † indicates significant (p <0.05) main effect for intensity within a mode. MODex: 
moderate exercise. VIGex: vigorous exercise. EDV: end diastolic volume. EF: ejection fraction. SVR: 








Figure 1  Heart rate response from moderate to vigorous exercise across treadmill and 
cycle exercise. * indicating significant (p <0.05) main effect for mode. † indicating 




























Figure 2  Stroke Volume response from moderate to vigorous exercise across treadmill 
and cycle exercise. * indicating significant (p <0.05) main effect for mode. † indicating 





























Figure 3  End Diastolic Volume response from moderate to vigorous exercise across 
treadmill and cycle exercise. * indicating significant (p <0.05) main effect for mode. † 


























Figure 4  Contractility Index response from moderate to vigorous exercise across treadmill 
and cycle exercise. * indicating significant (p <0.05) main effect for mode. † indicating 





















James Madison University 





You are being asked to volunteer for a research study conducted by Dr. Trent Hargens 
from James Madison University entitled, “Reliability of Impedance Cardiography in the 
Measurement of Cardiovascular Hemodynamics During Exercise”. 
 
The goal of this study is to examine whether a method for non-invasively measuring 




You will be asked to visit the Human Performance Laboratory (HPL) in Godwin Hall 4 
times over the course of about 2 – 4 weeks.  Your total time commitment for 
participation in this study will be about 4 hours (each visit about an hour). 
 
Upon completion of this informed consent, you will be asked to complete 2 short 
questionnaires, 1 that asks about your ability to participate in physical activity, and 1 
that asks about your current level of physical activity participation.  Each of these 
questionnaires should take about 5 minutes to complete.   
 
You will then have your height and weight measured.  Upon completion of this, you will 
be asked to complete a maximal treadmill exercise test.  During the test, researchers will 
monitor your heart rate, blood pressure and your perceived exertion to the workload 
you will be doing.  You will have several electrode patches placed on your skin on your 
torso, back and neck.  These will be connected to the device measuring the variables we 
are interested in studying.  During the test, you will breathe only through a mouthpiece, 
with your nose clamped off, so that we can measure the amount of oxygen you use 
during exercise.  The treadmill will start with a very slow speed and little grade, and will 
steadily increase in speed and grade throughout the test, so it will start easy, and 
become very intense.  At the end of the test, it should be a best effort on your part.  It 
may be as hard as any exercise you remember doing.  The exercise test will last about 10 
– 15 minutes.  Prior to your arrival to the HPL that day, you will be asked to refrain from 
eating for 4 hours prior to your arrival, and to avoid caffeine and alcohol for that time 
period as well. 
 
Upon completion of this visit, you will be asked to return to the HPL 3 subsequent times, 
a minimum of 48 hours later, and at the same time of day as the first visit.  The 




visit 1, or a maximal cycle exercise test.  For the cycle test, you will be asked to pedal a 
cycle ergometer at a certain work rate that will steadily increase in difficulty until you 
are no longer able to maintain at least 50 rpm.  It will start fairly easy, and become very 
intense, in a similar fashion to the treadmill.  We will measure the same things during 
the cycle test as we do during the treadmill test.  What type of test you complete 





There is a risk of abnormal changes during the maximal exercise tests.  These changes 
may include abnormal blood pressure, fainting, heart rhythm disorders, stroke, heart 
attack, and death.  The chance of serious heart problems during maximal exercise 
among adults is very small (less than 1/10,000 maximal exercise tests).  Every effort will 
be made to minimize risks of an abnormal response by reviewing you health history and 
providing adequate supervision of the exercise test.  All staff are certified by the 
American Heart Association in BLS (Basic Life Support), and all tests will be supervised by 




Participation may include knowledge about your health status.  You will receive 




If you have any questions or concerns or you would like to receive a copy of the final 
aggregate results of this study, please contact Dr. Trent Hargens at hargenta@jmu.edu 
or (540) 568-5844.  
 
Questions about Your Rights as a Research Subject 
Dr. David Cockley      
Chair, Institutional Review Board    
James Madison University     
(540) 568-2834       




All data and results will be kept confidential. You will be assigned an identification 
number and a pseudonym in place of your real name. At no time will your name be 
identified with your individual data. The researcher retains the right to use and publish 
non-identifiable data. All paper data will be kept secured in a locked cabinet in a locked 




file folders.  Upon completion of the study, only de-identified data will be kept for 
research dissemination purposes, and will be kept indefinitely.  All material containing 
identifiable information will be destroyed.  Final aggregate results will be made available 
to participants upon request. 
 
Freedom of Consent 
 
Your participation is entirely voluntary.  You are free to choose not to participate.  
Should you choose to participate, you can withdraw at any time without consequences 
of any kind. 
 
I have read this consent form and I understand what is being requested of me as a 
participant in this study.  I freely consent to participate.  I have been given satisfactory 
answers to my questions.  The investigator provided me with a copy of this form I 
requested it.  I certify that I am at least 18 years of age.  By clicking "Yes" to the question 










PAR-Q & YOU 
(A questionnaire for People Aged 15-69) 
Regular physical activity is fun and healthy, and increasingly more people are starting to become more active every day. Being more 
active is very safe for most people. However, some people should check with your doctor before you start.  
 
If you are planning to become much more physically active than you are now, start by answering the seven questions in the box 
below. If you are between the ages of 15 and 69, the PAR-Q will tell you if you should check with your doctor before you start. If you 
are over 69 years of age, and you are not used to being very active, check with your doctor. 
 
Common sense is your best guide when you answer these questions. Please read the questions carefully and answer each one 
honestly: check YES or NO 
 
  
YES      NO  
1. Has your doctor ever said that you have a heart condition and that you should only do physical activity recommended 
    by a doctor? 
YES      NO  2. Do you feel pain in your chest when you do physical activity? 
YES      NO  3. In the past month, have you had chest pain when you were not doing physical activity? 
YES      NO  4. Do you lose your balance because of dizziness or do you ever lose consciousness? 
YES      NO  
5. Do you have a bone or joint problem (for example, back, knee or hip) that could be made worse by a change in your  
    physical activity? 
YES      NO  6. Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart condition? 
YES      NO  7. Do you have a diabetes or thyroid condition? 










YES to one or more questions 
A medical clearance form is required of all participants who answer ‘yes’ to any of the eight PAR-Q questions.   
Note: Personal training staff reserve the right to require medical clearance from any client they feel may be at risk. 
•    
Discuss with your personal doctor any conditions that may affect your exercise program. 
•    
All precautions must be documented on the medical clearance form by your personal doctor. 
 
 
NO to all questions 
If you answered NO honestly to all PAR-Q questions, you 
can be reasonably sure that you can:  
•    start becoming much more physically active - 
begin slowly and build up gradually. This is the 
safest and easiest way to go. 
•    take part in a fitness appraisal - this is an 
excellent way to determine your basic fitness so 
that you can plan the best way for you to live 
actively. It is also highly recommended that you 
have your blood pressure evaluated. If your 
reading is over 144/94, talk with your doctor 





DELAY BECOMING MUCH MORE ACTIVE:  
•    If you are not feeling well because of a 
temporary illness such a cold or a fever - 
wait until you feel better; or 
•    If you are or may be pregnant - talk to your 




PLEASE NOTE:  If your health changes so that you 
then answer YES to any of the above questions, tell 
your fitness or health professionals. 




Informed Use of the PAR-Q: The Canadian Society for Exercise Physiology, Health Canada, and their agents assume no liability to persons who undertake physical 
activity, and if in doubt after completing this questionnaire, consult your doctor prior to physical activity. 
  























Note: This physical activity clearance is valid for a maximum of 12 months from the date it is 
completed and becomes invalid if your condition changes so that you would answer YES to any 
of the seven questions. 
 
 Supported by:     Physical 








INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as 
part of their everyday lives.  The questions will ask you about the time you spent being 
physically active in the last 7 days.  Please answer each question even if you do not 
consider yourself to be an active person.  Please think about the activities you do at 
work, as part of your house and yard work, to get from place to place, and in your spare 
time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much 
harder than normal.  Think only about those physical activities that you did for at least 
10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical activities 
like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week 
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one 
of those days? 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you breathe 
somewhat harder than normal.  Think only about those physical activities that you did 
for at least 10 minutes at a time. 
 
3. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or doubles tennis?  
Do not include walking. 
 
_____ days per week 
 






4. How much time did you usually spend doing moderate physical activities on one 
of those days? 
_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
Think about the time you spent walking in the last 7 days.  This includes at work and at 
home, walking to travel from place to place, and any other walking that you might do 
solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at 
a time?   
 
_____ days per week 
  
   No walking     Skip to question 7 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
 
The last question is about the time you spent sitting on weekdays during the last 7 
days.  Include time spent at work, at home, while doing course work and during leisure 
time.  This may include time spent sitting at a desk, visiting friends, reading, or sitting or 
lying down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ hours per day  
_____ minutes per day  
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